Genetics, Biomedical Computing and Genomics Monthly Meeting – “Translational Science at CFCCC-Opportunities for Collaboration and Clinical Trials”, Farshid Dayyani, MD, PhD
Genetics, Biomedical Computing and Genomics Monthly Meeting – “Translational Science at CFCCC-Opportunities for Collaboration and Clinical Trials”, Farshid Dayyani, MD, PhD
Tuesday 05/07/2024
10:00 to 11:00 a.m. (PT)
Dr. Dayyani is a Professor of Clinical Medicine in the Division of Hematology/Oncology at University of California Irvine and board certified in Medical Oncology. He is also the Associate Director for Translational Science and the Medical Director of the Clinical Trials Unit at the Chao Family Comprehensive Cancer Center at UC Irvine.
Dr. Dayyani performs clinical and translational research in gastrointestinal and hepatobiliary carcinomas. He manages a wide portfolio of investigator initiated, NCI funded and industry sponsored clinical trials to develop novel treatment options and establish new biomarkers. He obtained his MD/PhD from LMU Munich, Germany, followed by a research fellowship and residency in internal medicine at Harvard Medical School, Boston. He then completed a combined clinical and research fellowship in medical oncology at the UT MD Anderson Cancer Center, Houston, TX. Dr. Dayyani also has industry experience as Global Clinical Lead for Oncology at Roche Diagnostics, Int. in Rotkreuz, Switzerland, prior to joining UC Irvine.
Translational Science at CFCCC-Opportunities for Collaboration and Clinical Trials – Video